ttac-0001
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 3, 2019 (NCT03720431)
Timeline
Indications
Mechanism of action
FLT1 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03856099 | Phase 2 | May 15, 2019 | PharmAbcine |
| NCT03722342 | Phase 1 | Jan 16, 2019 | PharmAbcine |
| NCT03720431 | Phase 1 | Jan 3, 2019 | PharmAbcine |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PharmAbcine | For profit | 3 | 3 | 2 | 2019 |
1 organizations
Page 1 / 1